Mangoceuticals settles lawsuit with 62,500 shares, gets $100k loan from CEO trust at 18%

MANGOCEUTICALS, INC.

Entered settlement with 1800 Diagonal Lending, issuing 62,500 restricted shares to dismiss lawsuit with prejudice (May 5, 2025).
Borrowed $100,000 from The Tiger Cub Trust (CEO-controlled) via 18% promissory note maturing May 2, 2026.
Two Series B Preferred conversions: 100 shares for 73,333 common (Apr 28) and 300 shares for 220,000 common (May 1).
Outstanding common shares now 11,034,023 after settlement and conversion issuances.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.